• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Vancomycin-resistant enterococcus infection in the hematopoietic stem cell transplant recipient: an overview of epidemiology, management, and prevention.造血干细胞移植受者中的耐万古霉素肠球菌感染：流行病学、管理及预防概述
F1000Res. 2018 Jan 2;7:3. doi: 10.12688/f1000research.11831.1. eCollection 2018.
2
Evaluation of risk factors for vancomycin-resistant Enterococcus bacteremia among previously colonized hematopoietic stem cell transplant patients.既往已定植的造血干细胞移植患者中耐万古霉素肠球菌血症危险因素的评估。
Transpl Infect Dis. 2013 Oct;15(5):466-73. doi: 10.1111/tid.12120. Epub 2013 Aug 4.
3
The clinical impact of vancomycin-resistant Enterococcus colonization and bloodstream infection in patients undergoing autologous transplantation.万古霉素耐药肠球菌定植及血流感染对接受自体移植患者的临床影响。
Transpl Infect Dis. 2015 Oct;17(5):688-94. doi: 10.1111/tid.12433. Epub 2015 Oct 3.
4
The changing epidemiology of vancomycin-resistant Enterococcus (VRE) bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients.异基因造血干细胞移植（HSCT）受者中万古霉素耐药肠球菌（VRE）菌血症的流行情况变化。
Biol Blood Marrow Transplant. 2010 Nov;16(11):1576-81. doi: 10.1016/j.bbmt.2010.05.008. Epub 2010 May 26.
5
Vancomycin-resistant Enterococcus colonization and bloodstream infection: prevalence, risk factors, and the impact on early outcomes after allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.耐万古霉素肠球菌定植与血流感染：急性髓系白血病患者异基因造血细胞移植后的患病率、危险因素及其对早期结局的影响
Transpl Infect Dis. 2016 Dec;18(6):913-920. doi: 10.1111/tid.12612. Epub 2016 Nov 11.
6
Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogeneic hematopoietic stem cell transplant.异基因造血干细胞移植后早期由耐万古霉素肠球菌引起的定植、血流感染及死亡率
Biol Blood Marrow Transplant. 2007 May;13(5):615-21. doi: 10.1016/j.bbmt.2007.01.078. Epub 2007 Mar 23.
7
Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer.癌症患者中耐万古霉素肠球菌的定植与感染
Am J Infect Control. 2006 Oct;34(8):534-6. doi: 10.1016/j.ajic.2006.04.205.
8
The clinical and molecular epidemiology of pre-transplant vancomycin-resistant enterococci colonization among liver transplant recipients.肝移植受者移植前耐万古霉素肠球菌定植的临床与分子流行病学
Clin Transplant. 2016 Mar;30(3):306-11. doi: 10.1111/ctr.12690. Epub 2016 Feb 9.
9
The risk of developing a vancomycin-resistant Enterococcus bloodstream infection for colonized patients.定植患者发生耐万古霉素肠球菌血流感染的风险。
Am J Infect Control. 2008 Dec;36(10):S175.e5-8. doi: 10.1016/j.ajic.2008.10.010.
10
Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical course.异基因骨髓移植后早期耐万古霉素肠球菌（VRE）菌血症与临床病程迅速恶化相关。
Bone Marrow Transplant. 2005 Mar;35(5):497-9. doi: 10.1038/sj.bmt.1704821.

引用本文的文献

1
Impact of Enterococcus infection in HSCT recipients: a national analysis.造血干细胞移植受者中肠球菌感染的影响：一项全国性分析。
Infez Med. 2025 Mar 1;33(1):114-124. doi: 10.53854/liim-3301-11. eCollection 2025.
2
Management of Recurrent Vancomycin-resistant Bacteremia With Oritavancin: A Case Report.复发性万古霉素耐药菌血症的奥他万古霉素治疗：一例报告。
In Vivo. 2024 Nov-Dec;38(6):3106-3111. doi: 10.21873/invivo.13795.
3
Global landscape of vancomycin-resistant enterococci in hematopoietic stem-cell transplantation patients: a systematic review and meta-analysis.血液干细胞移植患者中万古霉素耐药肠球菌的全球流行情况：系统评价和荟萃分析。
BMC Infect Dis. 2024 Oct 22;24(1):1191. doi: 10.1186/s12879-024-10100-0.
4
Gut Microbiota Disruption in Hematologic Cancer Therapy: Molecular Insights and Implications for Treatment Efficacy.血液系统恶性肿瘤治疗中肠道菌群失调：分子机制及对治疗效果的影响
Int J Mol Sci. 2024 Sep 24;25(19):10255. doi: 10.3390/ijms251910255.
5
Molecular Rapid Diagnostics Improve Time to Effective Therapy and Survival in Patients with Vancomycin-Resistant Bloodstream Infections.分子快速诊断改善耐万古霉素血流感染患者有效治疗时间及生存率。
Antibiotics (Basel). 2023 Jan 19;12(2):210. doi: 10.3390/antibiotics12020210.
6
Association of pre-transplant vancomycin resistant enterococcus colonization status on long-term outcomes of allogeneic-hematopoietic cell transplantation.移植前耐万古霉素肠球菌定植状态与异基因造血细胞移植长期预后的相关性
Bone Marrow Transplant. 2023 Mar;58(3):346-348. doi: 10.1038/s41409-022-01895-0. Epub 2022 Dec 16.
7
Phage Cocktails with Daptomycin and Ampicillin Eradicates Biofilm-Embedded Multidrug-Resistant with Preserved Phage Susceptibility.含达托霉素和氨苄西林的噬菌体鸡尾酒疗法可根除生物膜包裹的多重耐药菌且保留噬菌体敏感性。
Antibiotics (Basel). 2022 Aug 30;11(9):1175. doi: 10.3390/antibiotics11091175.
8
Genotypic characterization of vancomycin-resistant causing urinary tract infection in northern India.印度北部万古霉素耐药导致尿路感染的基因型特征。
Indian J Med Res. 2022 Mar;155(3&4):423-431. doi: 10.4103/ijmr.IJMR_2554_19.
9
Genomic and Functional Characterization of Vancomycin-Resistant Enterococci-Specific Bacteriophages in the Wax Moth Larvae Model.蜡螟幼虫模型中耐万古霉素肠球菌特异性噬菌体的基因组和功能表征
Pharmaceutics. 2022 Jul 30;14(8):1591. doi: 10.3390/pharmaceutics14081591.
10
Incidence of Vancomycin-Resistant Strains among Patients with Urinary Tract Infections.尿路感染患者中耐万古霉素菌株的发生率。
Antibiotics (Basel). 2022 Mar 18;11(3):408. doi: 10.3390/antibiotics11030408.

本文引用的文献

1
The emerging problem of linezolid-resistant enterococci.耐(linezolid)利(novel)糖(tetracycline)肠球菌的新兴问题。
J Glob Antimicrob Resist. 2018 Jun;13:11-19. doi: 10.1016/j.jgar.2017.10.018. Epub 2017 Oct 31.
2
Evaluation of contact precautions for methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus.耐甲氧西林金黄色葡萄球菌和耐万古霉素肠球菌接触预防措施的评估。
Am J Infect Control. 2017 Dec 1;45(12):1369-1371. doi: 10.1016/j.ajic.2017.06.017. Epub 2017 Aug 24.
3
Comparative Pharmacodynamics of Single-Dose Oritavancin and Daily High-Dose Daptomycin Regimens against Vancomycin-Resistant Enterococcus faecium Isolates in an Pharmacokinetic/Pharmacodynamic Model of Infection.单次剂量奥他万古霉素与每日高剂量达托霉素方案治疗耐万古霉素粪肠球菌感染的比较药效动力学/药效动力学模型研究。
Antimicrob Agents Chemother. 2017 Sep 22;61(10). doi: 10.1128/AAC.01265-17. Print 2017 Oct.
4
Contact Precautions for Endemic MRSA and VRE: Time to Retire Legal Mandates.耐甲氧西林金黄色葡萄球菌（MRSA）和耐万古霉素肠球菌（VRE）的接触预防措施：是时候废除法律规定了。
JAMA. 2017 Jul 25;318(4):329-330. doi: 10.1001/jama.2017.7419.
5
Effect of Cessation of Contact Isolation for Endemic Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.针对地方性耐甲氧西林金黄色葡萄球菌和耐万古霉素肠球菌停止接触隔离的效果。
Infect Control Hosp Epidemiol. 2017 Aug;38(8):1005-1007. doi: 10.1017/ice.2017.122. Epub 2017 Jun 8.
6
Daptomycin nonsusceptible vancomycin resistant Enterococcus bloodstream infections in patients with hematological malignancies: risk factors and outcomes.血液系统恶性肿瘤患者中达托霉素不敏感、耐万古霉素肠球菌血流感染：危险因素及结局
Leuk Lymphoma. 2017 Dec;58(12):2852-2858. doi: 10.1080/10428194.2017.1312665. Epub 2017 Apr 12.
7
Prediction of Bloodstream Infection Due to Vancomycin-Resistant Enterococcus in Patients Undergoing Leukemia Induction or Hematopoietic Stem-Cell Transplantation.白血病诱导或造血干细胞移植患者中万古霉素耐药肠球菌血流感染的预测。
Clin Infect Dis. 2017 Jun 15;64(12):1753-1759. doi: 10.1093/cid/cix232.
8
Role of Combination Antimicrobial Therapy for Vancomycin-Resistant Enterococcus faecium Infections: Review of the Current Evidence.联合抗菌疗法在耐万古霉素屎肠球菌感染中的作用：当前证据综述
Pharmacotherapy. 2017 May;37(5):579-592. doi: 10.1002/phar.1922. Epub 2017 May 9.
9
Effect of Continuous and Sequential Therapy among Veterans Receiving Daptomycin or Linezolid for Vancomycin-Resistant Enterococcus faecium Bacteremia.接受达托霉素或利奈唑胺治疗耐万古霉素屎肠球菌血症的退伍军人中持续治疗与序贯治疗的效果
Antimicrob Agents Chemother. 2017 Apr 24;61(5). doi: 10.1128/AAC.02216-16. Print 2017 May.
10
Screening for vancomycin-resistant enterococci with Xpert® : diagnostic accuracy and impact on infection control decision making.使用Xpert®检测耐万古霉素肠球菌：诊断准确性及对感染控制决策的影响
New Microbes New Infect. 2017 Jan 12;16:54-59. doi: 10.1016/j.nmni.2016.12.020. eCollection 2017 Mar.

造血干细胞移植受者中的耐万古霉素肠球菌感染：流行病学、管理及预防概述

Vancomycin-resistant enterococcus infection in the hematopoietic stem cell transplant recipient: an overview of epidemiology, management, and prevention.

作者信息

Benamu Esther, Deresinski Stanley

机构信息

Division of Infectious Diseases, Department of Medicine, University of Colorado, Aurora, USA.

Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, USA.

出版信息

F1000Res. 2018 Jan 2;7:3. doi: 10.12688/f1000research.11831.1. eCollection 2018.

DOI:10.12688/f1000research.11831.1
PMID:29333263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5750719/
Abstract

Vancomycin-resistant (VRE) is now one of the leading causes of nosocomial infections in the United States. Hematopoietic stem cell transplantation (HSCT) recipients are at increased risk of VRE colonization and infection. VRE has emerged as a major cause of bacteremia in this population, raising important clinical questions regarding the role and impact of VRE colonization and infection in HSCT outcomes as well as the optimal means of prevention and treatment. We review here the published literature and scientific advances addressing these thorny issues and provide a rational framework for their approach.

摘要

耐万古霉素肠球菌（VRE）现已成为美国医院感染的主要原因之一。造血干细胞移植（HSCT）受者发生VRE定植和感染的风险增加。VRE已成为该人群菌血症的主要原因，引发了关于VRE定植和感染在HSCT结局中的作用和影响以及最佳预防和治疗方法的重要临床问题。我们在此回顾已发表的文献和针对这些棘手问题的科学进展，并为解决这些问题提供一个合理的框架。